Critical Comparison: Applied Dna Sciences (NASDAQ:BNBX) vs. 20/20 Biolabs (NASDAQ:AIDX)

Chronological Source Flow
Back

AI Fusion Summary

20/20 Biolabs (NASDAQ:AIDX) reports $2.04 M revenue and higher earnings than Applied DNA Sciences (NASDAQ:BNBX), which has $2.14 M revenue but a $15.16 M loss. Both are small‑cap services firms with limited valuation data and modest institutional ownership.
#20/20 Biolabs #Applied DNA Sciences #small‑cap #revenue comparison #earnings #institutional ownership #valuation #biotech services
25/03 07:26 defenseworld.net
2 Πηγές

Critical Comparison: Applied Dna Sciences (NASDAQ:BNBX) vs. 20/20 Biolabs (NASDAQ:AIDX)

20/20 BiolabsApplied DNA Sciencessmall‑caprevenue comparisonearningsinstitutional ownership
25/03 08:46 defenseworld.net

Reviewing Applied Dna Sciences (NASDAQ:BNBX) and 20/20 Biolabs (NASDAQ:AIDX)

COMPARISON ARTICLESPOLITICSCOMPANIES
Comments
Loading...
0